Equipmake Holdings Plc — Director's Dealing 2026

Mar 27, 2026

National Storage Mechanism | Additional information

RNS Number : 3461Y

Equipmake Holdings PLC

27 March 2026

27 March 2026

Equipmake Holdings plc

("Equipmake" or the "Company")

Director's Dealings

Equipmake announces that it has been notified of the following acquisition of ordinary shares in the Company undertaken by Tim Metcalfe, Non-Executive Chairman, details of which are set out in the notification below.

Following this purchase, Mr Metcalfe, together with shares held by his wife, holds 2,226,752 ordinary shares, representing approximately 0.20% of the Company's issued share capital.

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Timothy Mark Metcalfe

2.

Reason for the Notification

a)

Position/status

Director, Non-Executive Chairman

b)

Initial notification / Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Equipmake Holdings plc

b)

LEI

213800NY1WGJ26E4HB59

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of £0.0001 each

Identification Code

GB00BMBVXB73

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

	Price(s)	Volume(s)
	1.22 pence per Ordinary Share	163,934 Ordinary Shares

d)

Aggregated information:

· Aggregated volume

· Price

163,934

£2,000

e)

Date of the transaction

26 March 2026

f)

Place of the Transaction

Aquis Stock Exchange

For further information, please contact:

Equipmake Tim Metcalfe, Non-executive Chairman Ian Foley, CEO Ian Selby, CFO	Via IFC Advisory
VSA Capital (Financial Adviser, Aquis Corporate Adviser and Broker) Andrew Raca / Brian Wong	Tel: +44 (0) 20 3005 5000
IFC Advisory (Financial PR and IR Adviser) Graham Herring / Florence Staton	Tel: +44 (0)20 3934 6632 [email protected]

Sign up for Equipmake updates here: https://investors.equipmake.co.uk/auth/signup

About Equipmake

Equipmake is a UK-based industrial technology company specialising in the engineering, development and production of electrification products to meet the needs of the automotive and other sectors in support of the transition from fossil-fuelled to zero-emission drivetrains.

Equipmake is a leader in high performance technologically advanced electric motors, inverters and complete zero-emission electric drivetrains and power electronic systems. Equipmake has developed a vertically integrated solution providing fully bespoke solutions to its customers. The Company is focussed on accelerating traction with OEM and Tier 1 suppliers in relation to higher margin component and drivetrain supply under long-term growth contracts.

Key differentiators of the Company offerings are its advanced technology and performance, reliability and adherence to ASIL-D1 functional safety. Equipmake's advanced motor and inverter technology, featuring ASIL-D compliance, are designed to customers' highest functional safety standards. With decades of experience in electric drivetrain integration and a dedicated prototype vehicle testing facility, Equipmake can significantly accelerate product development for customers.

1 Automotive Safety Integrity Level ("ASIL") is a risk classification scheme defined by the ISO 26262 - Functional Safety for Road Vehicles standard and is a critical requirement for road vehicles. Of the four ASILs identified by the standard, ASIL-D dictates the highest integrity requirements on the product, which require exceptional rigour in their development.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXPPUMCWUPQGMQ